Eliem Therapeutics

Eliem Therapeutics is a clinical-stage biotechnology company focused on developing new therapies for disorders of neuronal excitability to address the needs of chronic pain, psychiatry, epilepsy, and other peripheral and central nervous system diseases. We will leverage our world-class expertise in neuroscience, translational medicine, and clinical development to meet this unmet medical need with a highly innovative pipeline. We are developing a new generation of pain medications to improve patients' quality of life, and the company is advancing two clinical-stage assets with clinically validated mechanisms of action for the treatment of neurological disorders.